FDAnews Drug Daily Bulletin

Drug Firm Valeant to Acquire Medicis

Sept. 5, 2012
A A
Valeant Pharmaceuticals International has agreed to buy Medicis Pharmaceutical for $2.6 billion, the latest in a string of acquisitions that have transformed the Canadian drug maker into a multibillion-dollar global company.
The Wall Street Journal